Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults-Reference-Cited by-同舟云学术

Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults

Published:2018-03 Issue:11 Volume:36 Page:1477-1483
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Suaya José A.,Jiang Qin,Scott Daniel A.,Gruber William C.,Webber Chris,Schmoele-Thoma Beate,Hall-Murray Cassandra K.,Jodar Luis,Isturiz Raul E.

Funder

Pfizer

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference37 articles.

1. Clinical and economic burden of community-acquired pneumonia among adults in Europe;Welte;Thorax,2012

2. Community-acquired pneumonia requiring hospitalization among U.S. adults;Jain;N Engl J Med,2015

3. Guidelines for the management of adult lower respiratory tract infections–full version;Woodhead;Clin Microbiol Infect,2011

4. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP);Kobayashi;MMWR Morb Mortal Wkly Rep,2015

5. Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe;Castiglia;Adv Ther,2014

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Status and Future Trends of Pneumococcal Vaccination in Chronic Obstructive Pulmonary Disease;Journal of Advanced Lung Health;2024-03-29

2. Strategies for pneumococcal vaccination in older adults in the coming era;Human Vaccines & Immunotherapeutics;2024-03-22

3. Bacterial Vaccinations in Patients with Chronic Obstructive Pulmonary Disease;Vaccines;2024-02-18

4. Evaluation of Relationship Between Conjugated Pneumococcal Vaccine (PCV13) and Respiratory Tract Infection Frequency in Inviduals Aged SixtyFive and Over;Flora the Journal of Infectious Diseases and Clinical Microbiology;2023-12-22

5. A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom;Expert Review of Vaccines;2023-09-11